Syndax Pharmaceuticals (SNDX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

SNDX is expected to report earnings to rise 40.00% to -112 cents per share on November 06

Syndax Pharmaceuticals SNDX Stock Earnings Reports

Q3'24

Est.

$-1.12

Q2'24

Beat

by $0.11

Q1'24

Beat

by $0.14

Q4'23

Missed

by $0.03

Q3'23

Beat

by $0.06

The last earnings report on August 01 showed earnings per share of -80 cents, beating the estimate of -91 cents. With 1.84M shares outstanding, the current market capitalization sits at 1.61B.

View a ticker or compare two or three

Compare

SNDX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For SNDX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for SNDX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of biopharmaceuticals for novel cancer therapies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

35 Gatehouse Drive

Phone

+1 781 419-1400

Employees

184

Web

https://www.syndax.com